Anixa Biosciences stockholders re-elect four directors, approve say-on-pay, ratify auditor

Proposal No. 1 – Election of directors Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. were each re-elected to serve until the 2024 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 10,263,393 940,600 9,765,865 Dr. Arnold Baskies 10,273,898 930,095 9,765,865 Emily Gottschalk 10,055,355 1,148,638 9,765,865 Lewis H. Titterton, Jr. 9,825,204 1,378,789 9,765,865

Proposal No. 3 – Ratification of the appointment of independent registered public accounting firm The appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2023 was ratified. The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 20,439,779 61,616 468,463 -

Proposal No. 2 – Approval, by non-binding advisory vote, of the Company’s executive compensation The Company’s executive compensation, by non-binding advisory vote, was approved. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 9,166,107 1,816,322 221,564 9,765,865